{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:18:10Z","timestamp":1762175890079,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.amjmed.2005.09.040","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T14:00:46Z","timestamp":1137679246000},"page":"88-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S2","title":["Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms"],"prefix":"10.1016","volume":"118","author":[{"given":"James H.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.09.040_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/annonc\/mdf151","article-title":"Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients","volume":"13","author":"Bertelli","year":"2002","journal-title":"Ann Oncol."},{"key":"10.1016\/j.amjmed.2005.09.040_bib2","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#","article-title":"Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes","volume":"82","author":"Quella","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.amjmed.2005.09.040_bib3","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.amjmed.2005.09.040_bib4","first-page":"558","article-title":"Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis","volume":"75","author":"Surrey","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jcem-70-4-920","article-title":"Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?","volume":"70","author":"Riis","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib6","first-page":"3561","article-title":"Sexual dimorphism in the influence of advancing aging on adrenal hormone levels","volume":"85","author":"Laughlin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1210\/jcem-71-4-900","article-title":"Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women","volume":"71","author":"Liu","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jcem-71-3-696","article-title":"The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women","volume":"71","author":"Mortola","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib9","first-page":"1360","article-title":"Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age","volume":"78","author":"Morales","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.fertnstert.2003.06.005","article-title":"Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids","volume":"80","author":"Genazzani","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.amjmed.2005.09.040_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1530\/eje.0.1450457","article-title":"Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women","volume":"145","author":"Lasco","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.amjmed.2005.09.040_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/152460902753645290","article-title":"Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women","volume":"11","author":"Hackbert","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.amjmed.2005.09.040_bib13","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jcem.82.10.4306","article-title":"Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women","volume":"82","author":"Labrie","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yhbeh.2003.09.008","article-title":"Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women","volume":"45","author":"Hirshman","year":"2004","journal-title":"Horm Behav"},{"key":"10.1016\/j.amjmed.2005.09.040_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5122(86)90025-3","article-title":"Steroid and gonadotropin levels in women during the peri-menopausal years","volume":"8","author":"Longcope","year":"1986","journal-title":"Maturitas"},{"key":"10.1016\/j.amjmed.2005.09.040_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jcem-39-6-1020","article-title":"Endocrine function of the postmenopausal ovary","volume":"39","author":"Judd","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib17","first-page":"138","article-title":"Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women","volume":"6","author":"Simon","year":"1999","journal-title":"Menopause"},{"key":"10.1016\/j.amjmed.2005.09.040_bib18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9378(84)90746-4","article-title":"Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flashes in the surgical menopause","volume":"148","author":"Sherwin","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2005.09.040_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9378(85)90001-8","article-title":"Differential symptom response to parenteral estrogen and\/or androgen administration in surgical menopause","volume":"151","author":"Sherwin","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2005.09.040_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0306-4530(85)90009-5","article-title":"Sex steroids and affect in the surgical menopause","volume":"10","author":"Sherwin","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.amjmed.2005.09.040_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-0327(88)90061-4","article-title":"Affective changes with estrogen and androgen replacement therapy in surgically menopausal women","volume":"14","author":"Sherwin","year":"1988","journal-title":"J Affect Disord"},{"key":"10.1016\/j.amjmed.2005.09.040_bib22","first-page":"1012","article-title":"A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women","volume":"44","author":"Barrett-Connor","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.amjmed.2005.09.040_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal testosterone treatment in women with impaired sexual function after oophorectomy","volume":"343","author":"Shifren","year":"2000","journal-title":"N Engl J Med"},{"year":"2004","series-title":"Two phase III studies demonstrate testosterone transdermal patch improves sexual activity and sexual desire in surgically menopausal women.","author":"Kingsberg","key":"10.1016\/j.amjmed.2005.09.040_bib24"},{"key":"10.1016\/j.amjmed.2005.09.040_bib25","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1016\/j.fertnstert.2004.07.197","article-title":"Testosterone transdermal patch (TTP) significantly improved sexual function in naturally menopausal women in a large phase III study [abstract]","volume":"82","author":"Kroll","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.amjmed.2005.09.040_bib26","first-page":"P-87","article-title":"Safety and tolerability of transdermal testosterone therapy versus placebo in surgically menopausal women receiving oral or transdermal estrogen [abstract]","volume":"9","author":"Simon","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.amjmed.2005.09.040_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","article-title":"Tibolone for postmenopausal women","volume":"87","author":"Modelska","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1471-0528.2002.02020.x","article-title":"Dose-response analysis of effects of tibolone on climacteric symptoms","volume":"109","author":"Landgren","year":"2002","journal-title":"BJOG"},{"issue":"suppl","key":"10.1016\/j.amjmed.2005.09.040_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-5122(87)90041-7","article-title":"Effects of Org OD 14 on pituitary and peripheral \u03b2-endorphin in castrated rats and post-menopausal women","volume":"1","author":"Genazzani","year":"1987","journal-title":"Maturitas"},{"key":"10.1016\/j.amjmed.2005.09.040_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5122(96)01069-9","article-title":"Effect on sexual life\u2014a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen","volume":"26","author":"Nathorst-Boos","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.amjmed.2005.09.040_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0015-0282(00)01768-4","article-title":"Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy","volume":"75","author":"Doren","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.amjmed.2005.09.040_bib32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-0528.1998.tb10237.x","article-title":"A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms","volume":"105","author":"Hammar","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.amjmed.2005.09.040_bib33","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jcem.86.10.7937","article-title":"Prevention of bone loss with tibolone in postmenopausal women","volume":"86","author":"Gallagher","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.09.040_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5122(00)00103-1","article-title":"Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women","volume":"35","author":"Berning","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.amjmed.2005.09.040_bib35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1471-0528.2002.01338.x","article-title":"Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women","volume":"109","author":"Huber","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.amjmed.2005.09.040_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.fertnstert.2003.07.041","article-title":"Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women","volume":"81","author":"Valdivia","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.amjmed.2005.09.040_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1067\/mob.2002.121896","article-title":"Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density","volume":"186","author":"Lundstrom","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2005.09.040_bib38","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jcem.82.6.3995","article-title":"Tibolone","volume":"82","author":"Bjarnason","year":"1997","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305009009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305009009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:41:45Z","timestamp":1757580105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305009009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0002934305009009"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.09.040","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}